Search

everythinglearnresearchcommunity

for

Search:↓

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Finasteride, a medication, is being re-evaluated for its effects and uses.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Rats had lasting erectile problems after stopping a certain medication.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

β-sitosterol and brassicasterol may help treat hair loss.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Gene variation affects prostate issues and hair loss.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.